Ganciclovir Sodium
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 317965

CAS#: 107910-75-8 (sodium)

Description: Ganciclovir Sodium is an acyclovir analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.


Chemical Structure

img
Ganciclovir Sodium
CAS# 107910-75-8 (sodium)

Theoretical Analysis

MedKoo Cat#: 317965
Name: Ganciclovir Sodium
CAS#: 107910-75-8 (sodium)
Chemical Formula: C9H12N5NaO4
Exact Mass: 277.0787
Molecular Weight: 277.21
Elemental Analysis: C, 38.99; H, 4.36; N, 25.26; Na, 8.29; O, 23.09

Price and Availability

Size Price Availability Quantity
5.0g USD 250.0 2 Weeks
10.0g USD 450.0 2 Weeks
25.0g USD 650.0 2 Weeks
50.0g USD 850.0 2 Weeks
100.0g USD 1250.0 2 Weeks
200.0g USD 1950.0 2 Weeks
500.0g USD 2950.0 2 Weeks
1.0kg USD 4850.0 2 Weeks
Click to view more sizes and prices
Bulk inquiry

Related CAS #: 82410-32-0 (free)   1359968-33-4 (hydrate)   84245-13-6 (x sodium)   107910-75-8 (sodium)   352346-23-7 (potassium)    

Synonym: Ganciclovir Sodium; RS-21592 sodium; Cytovene IV; RS 21592 Sodium; BIOLF-62; BW-759 sodium; Cytovene;

IUPAC/Chemical Name: sodium;2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)purin-6-olate

InChi Key: JJICLMJFIKGAAU-UHFFFAOYSA-M

InChi Code: InChI=1S/C9H13N5O4.Na/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16;/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17);/q;+1/p-1

SMILES Code: C1=NC2=C(N1COC(CO)CO)N=C(N=C2[O-])N.[Na+]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Product Data:

Biological target: Ganciclovir (RS-21592, BW-759, 2'-Nor-2'-deoxyguanosine) is an antiviral drug for feline herpesvirus type-1 with IC50 of 5.2 μM in a cell-free assay.
In vitro activity: A correlation was found between the dose of ganciclovir exposure and a decrease in total cell number when duration exceeded 2 days (r(2)=0.92 and 0.93 after 7 and 14 days, respectively). High levels (20 mg/l) of ganciclovir were not more toxic than lowest levels (1 mg/l) for the shortest durations of ganciclovir exposure (1 and 2 days). Moreover, 50% cytotoxic concentrations markedly decreased with the duration of ganciclovir exposure (374-3 mg/l from 1 to 14 days respectively) after 14 days of culture. Reference: Antivir Chem Chemother. 2009;19(6):257-62. https://pubmed.ncbi.nlm.nih.gov/19641234/
In vivo activity: Ganciclovir (GCV)-treated CMV-infected mice had lower ABR (P < 0.0001, Kruskal-Wallis test) and DPOAE (P < 0.0001) thresholds compared to CMV-infected untreated mice, indicating that GCV protected mice from CMV-induced hearing loss. Viral load in infected populations undergoing GCV treatment was significantly decreased (P = 0.03) relative to untreated mice. GCV treatment alone had no effect on ABR and DPOAE compared to untreated, uninfected controls (P = 0.1, P = 0.24, respectively). GCVtreated mice received increased protection from OHC loss when compared to untreated groups, with total OHC losses of approximately 7% and 14%, respectively (P < 0.05). Neutropenia was absent after 7 days of GCV treatment. Reference: Laryngoscope. 2020 Apr;130(4):1064-1069. https://pubmed.ncbi.nlm.nih.gov/31184781/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 5.0 18.04
Water 50.0 180.37

Preparing Stock Solutions

The following data is based on the product molecular weight 277.21 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Janoly-Dumenil A, Rouvet I, Bleyzac N, Bertrand Y, Aulagner G, Zabot MT. Effect of duration and intensity of ganciclovir exposure on lymphoblastoid cell toxicity. Antivir Chem Chemother. 2009;19(6):257-62. doi: 10.1177/095632020901900605. PMID: 19641234. 2. Ding Z, Mathur V, Ho PP, James ML, Lucin KM, Hoehne A, Alabsi H, Gambhir SS, Steinman L, Luo J, Wyss-Coray T. Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation. J Exp Med. 2014 Feb 10;211(2):189-98. doi: 10.1084/jem.20120696. Epub 2014 Feb 3. PMID: 24493798; PMCID: PMC3920559. 3. Janoly-Dumenil A, Rouvet I, Bleyzac N, Bertrand Y, Aulagner G, Zabot MT. Effect of duration and intensity of ganciclovir exposure on lymphoblastoid cell toxicity. Antivir Chem Chemother. 2009;19(6):257-62. doi: 10.1177/095632020901900605. PMID: 19641234.
In vitro protocol: 1. Janoly-Dumenil A, Rouvet I, Bleyzac N, Bertrand Y, Aulagner G, Zabot MT. Effect of duration and intensity of ganciclovir exposure on lymphoblastoid cell toxicity. Antivir Chem Chemother. 2009;19(6):257-62. doi: 10.1177/095632020901900605. PMID: 19641234. 2. Ding Z, Mathur V, Ho PP, James ML, Lucin KM, Hoehne A, Alabsi H, Gambhir SS, Steinman L, Luo J, Wyss-Coray T. Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation. J Exp Med. 2014 Feb 10;211(2):189-98. doi: 10.1084/jem.20120696. Epub 2014 Feb 3. PMID: 24493798; PMCID: PMC3920559.
In vivo protocol: 1. Haller TJ, Price MS, Lindsay SR, Hillas E, Seipp M, Firpo MA, Park AH. Effects of ganciclovir treatment in a murine model of cytomegalovirus-induced hearing loss. Laryngoscope. 2020 Apr;130(4):1064-1069. doi: 10.1002/lary.28134. Epub 2019 Jun 11. PMID: 31184781. 2. Ding Z, Mathur V, Ho PP, James ML, Lucin KM, Hoehne A, Alabsi H, Gambhir SS, Steinman L, Luo J, Wyss-Coray T. Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation. J Exp Med. 2014 Feb 10;211(2):189-98. doi: 10.1084/jem.20120696. Epub 2014 Feb 3. PMID: 24493798; PMCID: PMC3920559.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Mulye NV, Turco SJ, Speaker TJ. Stability of ganciclovir sodium in an
infusion-pump syringe. Am J Hosp Pharm. 1994 May 15;51(10):1348-9. PubMed PMID:
8085576.

2: Johnson CE, Jacobson PA, Chan E. Stability of ganciclovir sodium and amino
acids in parenteral nutrient solutions. Am J Hosp Pharm. 1994 Feb 15;51(4):503-8.
PubMed PMID: 8017417.

3: Phaypradith S, Vigneron J, Perrin A, Durney-Archeray MJ, Hoffman MA, Hoffman
M. [Stability of dilute solutions of ganciclovir sodium (Cymevan) in
polypropylene syringes and PVC perfusion bags]. J Pharm Belg. 1992
Nov-Dec;47(6):494-8. French. PubMed PMID: 1289490.

4: Parasrampuria J, Li LC, Stelmach AH, Sykes TR, Gordon GA. Stability of
ganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injection
over 35 days. Am J Hosp Pharm. 1992 Jan;49(1):116-8. PubMed PMID: 1570851.

5: Silvestri AP, Mitrano FP, Baptista RJ, Williams DA. Stability and
compatibility of ganciclovir sodium in 5% dextrose injection over 35 days. Am J
Hosp Pharm. 1991 Dec;48(12):2641-3. PubMed PMID: 1814209.

6: Outman WR, Mitrano FP, Baptista RJ. Visual compatibility of ganciclovir sodium
and total parenteral nutrient solution during simulated Y-site injection. Am J
Hosp Pharm. 1991 Jul;48(7):1538-9. PubMed PMID: 1909095.

7: Visor GC, Lin LH, Jackson SE, Winterle JS, Lee G, Kenley RA. Stability of
ganciclovir sodium (DHPG sodium) in 5% dextrose or 0.9% sodium chloride
injections. Am J Hosp Pharm. 1986 Nov;43(11):2810-2. PubMed PMID: 3492139.